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Abstract
Background: Since the emergence of next generation sequencing platforms, unprecedented opportunities have
arisen in the study of natural vertebrate populations. In particular, insights into the genetic and epigenetic
mechanisms of adaptation can be revealed through study of the expression profiles of genes. However, as a pre-
requisite to expression profiling, care must be taken in RNA preparation as factors like DNA contamination, RNA
integrity or transcript abundance can affect downstream applications. Here, we evaluated five commonly used RNA
extraction methods using whole blood sampled under varying conditions from 20 wild carnivores.
Results: Despite the use of minute starting volumes, all methods produced quantifiable RNA extracts (1.4 –
18.4 μg) with varying integrity (RIN 4.6 - 7.7), the latter being significantly affected by the storage and extraction
method used. We observed a significant overall effect of the extraction method on DNA contamination. One
particular extraction method, the LeukoLOCK™ filter system, yielded high RNA integrity along with low DNA
contamination and efficient depletion of hemoglobin transcripts highly abundant in whole blood. In a proof of
concept sequencing experiment, we found globin RNA transcripts to occupy up to ¼ of all sequencing reads if
libraries were not depleted of hemoglobin prior to sequencing.
Conclusion: By carefully choosing the appropriate RNA extraction method, whole blood can become a valuable
source for high-throughput applications like expression arrays or transcriptome sequencing from natural
populations. Additionally, candidate genes showing signs of selection could subsequently be genotyped in large
population samples using whole blood as a source for RNA without harming individuals from rare or endangered
species.
Keywords: Whole blood, RNA preservation, RNA extraction, DNA contamination, Transcriptome sequencing, Globin
transcripts
Background
Adapting to an ever-changing environment is one of the
most crucial functions of living organisms. Although we
have a profound understanding of how some adaptive
mechanisms have shaped phenotypic traits (i.e. [1-3]),
their molecular foundation remains largely unexplored
in natural populations of vertebrates (i.e. [4,5]). Over the
last several decades, molecular studies addressing signa-
tures of selection have mainly focused on model organ-
isms or captive animals for which genome information
became readily available and sample material can be eas-
ily obtained [6-9]. Even though such studies provide fun-
damental knowledge for evolutionary biology, similar
studies on vertebrates in a natural context have thus far
only marginally been explored. With the emergence of
high-throughput applications such as expression arrays
and next generation sequencing methods (NGS) new
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mechanisms facilitating adaptation in natural popula-
tions [10-13]. Moreover, the introduction of transcrip-
tome sequencing via RNAseq [14,15] has led to
important findings in the field of ecological genomics
[16-18]. Owing to their high sensitivity, these novel tech-
nologies require special precautions in sample handling
and preparation, a pre-requisite not often achievable for
free-ranging, natural populations of vertebrates. For ex-
ample, fresh tissue collection for RNA extraction can be
difficult for rare or endangered species. Although sam-
pling via fat or muscle tissue biopsies may be possible in
some exceptional cases, the primary least invasive and
abundant source of RNA in vertebrates remains whole
blood.
Whole blood offers several advantages for transcrip-
tome studies on non-model organisms but is surprisingly
underrepresented in the recent literature. Blood has an
important role in mediating between the environment
and the organism and hence exploring gene expression
profiles derived from blood may provide deeper insight
into immune response or stress metabolism [19-22].
Furthermore, compared to other tissues, blood is rela-
tively easy to obtain and small volumes can be collected
with little harm to the animal. However, extracting use-
ful RNA from whole blood is hampered by several chal-
lenges. A first concern is the effective preservation of
RNA. RNA is sensitive to endogenous and exogenous
RNases, which rapidly degrade the nucleic acid resulting
in changes in the expression profile and a potential loss
of rare transcripts immediately after sample collection
[23-26]. Solutions to this dilemma include immediate
snap freezing of the sample in liquid nitrogen or dry ice
[27,28], or storage in special whole blood preservation
buffers. Snap freezing presents an alternative for some
but may be difficult for more remote and unpredictable
field situations. In contrast, storage buffers are easy to
transport and are purported to increase the time before
freezing becomes necessary and thus provide researchers
with the flexibility to ship samples from the field.
A second challenge of using whole blood for transcrip-
tome profiling is the heterogeneity of blood cells and the
high content of interfering hemoglobin mRNAs. Globin
mRNA in mammalian whole blood is estimated to ac-
count for 70% of all mRNA transcripts (i.e. [29]), an ex-
cess that significantly affects the detection sensitivity of
less abundant mRNAs in high-throughput approaches
and reduces the amount of target cDNA sequenced [29-
32]. In order to minimize the confounding effect of glo-
bin mRNA, methods have been suggested which reduce
the abundance of those transcripts prior to high-
throughput sequencing. These methods range from bio-
tinylated globin capture oligos, to a laborious fractionat-
ing of whole blood using microcentrifuges which
depletes the primary source of globin mRNA (reticulo-
cytes). Blood samples cannot be frozen or stored in pres-
ervation buffer for these approaches prior to processing
and hence these methods are impractical for field-based
investigations of natural, free-ranging populations. How-
ever, a recently launched, commercially available whole
blood filter system has been suggested to effectively filter
out reticulocytes while capturing and preserving leuko-
cytes, the cell population most interesting for investiga-
tions of adaptive response to changing environmental
conditions.
As encouraging as these preservation methods appear,
to our knowledge, their performance has never been
evaluated by concurrent experiments on different spe-
cies and using similar collection conditions. In the
present study, we evaluated four commercially available
RNA preservation buffers applied to whole blood sam-
ples in seven different carnivore species. Furthermore,
we explored the performance and the suitability of a
new whole blood filter system for application under field
conditions. All five sampling methods were evaluated
with regard to RNA quality including DNA contamin-
ation and RNA yield as well as the integrity of the iso-
lated RNA. In a proof-of-concept-experiment, we
modified and validated conditions of mRNA preparation
from whole blood samples for NGS applications. Finally,
we provide guidelines on how to preserve and process
RNA extracts from whole blood sampled from wildlife
populations.
Results
We evaluated different RNA extraction methods applied
to whole blood sampled under field conditions that re-
semble situations researchers face when investigating
non-model organisms in their natural habitat. We used
samples collected from 20 carnivores and RNA from
each individual was preserved using five methods (four
buffers and one filter each; except one individual for
which we only collected blood for the four whole blood
preservation buffers) resulting in a total of 99 RNA
extractions (Additional file 1: Figure S1, Additional file
1: Table S1).
Presence of contaminants in the RNA extracts from blood
samples
DNA might inadvertently be co-extracted with RNA and
thus negatively affect downstream applications. Since
most commonly used nucleic acid quantification proce-
dures evaluate both RNA and DNA simultaneously, we
explicitly tested each RNA extract for potential DNA
contamination by means of PCR amplifications.
In total, we examined four PCRs for each extract and
found 62 of 80 whole blood non-filtered extracts to con-
tain traces of DNA contamination. When considering
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PCRs resulted in amplification products (Table 1). The
RiboPure™ kit samples showed the highest percentage of
amplification and hence the largest amount of DNA
contamination. The successive PCRs were distributed
among 17 of the 20 tested extracts, leaving only 15.0%
free of DNA contamination. Of those RiboPure™ extracts
contaminated with DNA, a surprising 30.0% gave pro-
ducts for all four test PCRs. A modest amount of DNA
contamination was observed for samples extracted with
the PAXgene™ blood kit (overall 54.4% positive PCRs),
and lastly, TRIzol
W LS and RNeasy
W methods gave only
43.8% and 40.0% positive PCRs, respectively.
We additionally investigated the performance of a
commercially available kit (LeukoLOCK™) that filters
leukocytes and depletes the amount of reticulocytes
prior to extraction. We found that among the 19 pre-
filtered extracts only four samples yielded PCR amplifi-
cations. This corresponds to only 11% amplification rate
(Table 1) and is the lowest contamination rate observed
in this study. Despite this low degree of contamination,
two positive samples amplified three out of four test
products, a result indicating substantial contamination
within those affected extracts.
When testing if the extraction method, the species or
individual factors of each animal affected the DNA con-
tamination in the 99 RNA samples, only the extraction
method revealed a significant correlation (ANOVA:
p=2.948e
-07; Pearson’s Chi-squared test: p=1.254e
-09).
We also detected severe DNA contamination through
visual inspection of electropherograms in eight out of the
99 extracts processed on Agilent’s Bioanalyzer (Figure 1).
Interestingly, among the eight samples, the majority were
extracted using the RiboPure™ method and underscore the
tendency of this method to co-extract DNA. Finally, in
order to further reduce the DNA contamination of the
RNA extracts, we performed a second, more rigorous
DNase treatment of all extracts that yielded more than
two successful PCR amplifications as well as the eight
RNA samples showing visual DNA contamination on the
Bioanalyzer. This procedure effectively removed all detect-
able traces of DNA contaminants.
Besides DNA contamination, the presence of add-
itional contaminants such as proteins, salt and organic
compounds were determined by measuring the absorp-
tion at wavelengths A260/280 and A260/230 using
Nanodrop. We observed significant variation between
the different procedures (ANOVA: p=3.678e
-09 for
A260/280 and p=6.103e
-08 for A260/230). The A260/
280 ratio averaged between 1.9 and 2.1 for all extraction
kits (Table 1), while more variation was observed for
A260/230 ratios. Only the RiboPure™ kit resulted in a
A260/230 ratio of 2.1 indicating samples free of organic
compounds, followed by TRIzol
W LS (1.3±0.5), PAX-
gene™ (1.2±0.6), RNeasy
W (0.9±0.6) and LeukoLOCK™
with the lowest ratio (0.8± 0.5).
RNA yield and integrity
After complete depletion of contaminant DNA, we
determined the amount of extracted RNA. Starting from
minute volumes of only 500 μl whole blood (Additional
file 1: Figure S1), we obtained the following RNA yields
with significant variation between the applied methods
(ANOVA: p=4.653e
-10): 5.0-43.9 μgu s i n gR i b o P u r e ™;
0–6.2 μg for the RNeasy
W; 0.1-10.2 μgf o rt h eP A X g e n e ™
and 0.2-15.1 μg for samples extracted using TRIzol
W LS
(Table 1, Figure 2A). The RNA yield range adjusted for
500 μl filtered blood using LeukoLOCK™was amongst the
lowest with 0.1- 3.7 μg( T a b l e1 ,F i g u r e2 ) .
We further investigated the integrity of each RNA
extract as indicated by the RIN factor and observed the
following average values: 4.6±2.3 for samples extracted
using RiboPure™ (stored in RNAlater
W); 6.9±2.6 RNeasy
W
(stored in RNAprotect
W); 7.7±1.2 for PAXgene™ (stored
in PAXgene™ blood buffer), 6.2±2.9 TRIzol
W LS (stored in
TRIzol
W LS; Table 1, Figure 2B) and lastly a RIN value of
7.6±1.9 for the filtered blood (stored in RNAlater
W). The
values for RNA integrity differed significantly between
methods (ANOVA: p=0.007). In comparison to RNeasy
W
and PAXgene™, whole blood samples extracted with
Table 1 RNA integrity, yields and DNA contamination for each tested preservation buffer and extraction method
Approach Preservation
buffer
Extraction
kit/protocol
RIN RNA
yield
range
(μg/
500 μl
blood)
260/
280
260/
230
DNA contamination
% Amplification
1 % Individuals
with min.
1 amplicon
2
Whole blood RNAlater
W RiboPure™ 4.6± 2.3 5.0- 43.9 1.9± 0.1 2.1± 0.2 74.0 85.0
RNAprotect
W RNeasy
W 6.9± 2.6 0.0- 6.2 2.1± 0.2 0.9± 0.6 40.0 80.0
PAXgene™ PAXgene™ 7.7± 1.2 0.1- 10.2 2.1± 0.2 1.2± 0.6 54.4 95.0
TRIzol
W LS TRIzol
W LS 6.2± 2.9 0.2- 15.1 1.9± 0.1 1.3± 0.5 43.8 80.0
Filtered blood RNAlater
W LeukoLOCK™ 7.6± 1.9 0.1- 3.7 2.0± 0.1 0.8± 0.5 11.0 20.0
1Percentage of PCRs that resulted in positive amplification. Each PCR performed in four reactions that amplified were counted.
2 Percentage of individuals in which a minimum of a single amplification occurred.
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W LS or RiboPure™ showed a broad range of well-
preserved RNA samples to RNA samples totally degraded.
Due to low RNA concentrations in 12 samples, we lowered
the threshold parameters in the Agilent Bioanalyzer soft-
ware for these particular samples in order to obtain a RIN
value. These samples included a total of seven study ani-
mals (three bobcats, two foxes, one sea lion and one coy-
ote) and all extraction/ storage methods were affected.
We found a trend towards higher average RIN values
in extracts collected in a lab-like facility (i.e. in zoo facil-
ities; 7.4±1.4) when compared to those collected in the
field (5.8±1.2). Furthermore, we observed a significant
effect of the sample collector as well as the species
(p=0.002 and p=5.872e
-06, respectively) but these two
factors are not mutually exclusive (Additional file 1:
Table S1).
Hemoglobin depletion
In order to evaluate a potential reduction of hemoglobin
transcripts in the filtered extracts, we used a quantitative
PCR assay to estimate the relative ratio between
hemoglobin and three housekeeping genes and
Figure 1 Electropherograms exemplifying quality differences in various RNA extracts. Agilent 2100 Bioanalyzer electropherogram obtained
from one individual extracted using the Mouse RiboPure™ kit without DNase treatment (A); after one DNase treatments (B); and using the
RNeasy
W kit including one DNase treatment (C). The broadened peak for the 28 s ribosomal RNA in (A) indicates substantial DNA contamination
of the RNA samples. After DNase treatment, traces of partially sheared DNA are still visible below the 18 s peak (B). Samples extracted using the
RNeasy
W kit including one DNase treatment, give a clean electropherogram with well-defined 18 s and 28 s peaks with a high RIN value (C).
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other whole blood extraction methods. The average log
transformed ratio for hemoglobin in filtered blood was
significantly higher than that of whole blood (Figure 3,
Student’s t-test, p=0.005). On average, hemoglobin was
reduced by 70% in the extracts processed through the filter.
When three outliers are excluded, the average reduction
increased to 84%. Interestingly, we found a strong correl-
ation between the log transformed ratios and the species
used in this study (ANOVA: p=4.393e
-16). However, the
species were sampled by different researchers and this
could consequently also contribute this association.
454 sequencing results
Four cDNA samples were prepared differently for use
on a 454 GS FLX Titanium sequencer (Table 2). We first
assembled all raw reads per sample. Sample B2 showed
the lowest number of reads (17,047) with 4,391 reads
(25.76%) assembled into 309 contigs. Sample A2 had the
largest number of reads (38,601). Fifty percent of those
reads (19,318) were assembled into 2,286 contigs. The
remaining two samples A1 and B1, yielded 30,145 and
21,219 reads, from which 30.31% and 61.62% built 1,066
and 275 contigs, respectively. Interestingly, the number
of singletons (reads only occurring once and not
assembled in any contig), did not correlate with the total
number of reads per sample. For example, the sample
with the lowest number of reads (B2) yielded the highest
number of singletons (65.51%), the second highest
percentage of singletons (63.71%) was found in sample
A1, which in turn showed the second largest number of
total reads (Table 2). We detected 36.47% and 28.22%
singletons in samples A2 and B1, respectively. This re-
sult suggests that the number of total reads does not ne-
cessarily determine the abundance of singletons, but
additional factors such as tissue type or stochastic effects
need to be considered.
Figure 2 RNA yield and RIN values. RNA yield and RIN values for the five different RNA extraction protocols. (A) RNA yield (in μg) obtained
after one or (if required) two DNase treatments from 500 μl blood using four different protocols/ kits for RNA extraction from whole blood as
well as the LeukoLOCK™ filter system. (B) RIN values of the RNA extracted from blood samples preserved in different buffers. Please note that
samples collected with the RNA filter “Leuko” were stored in RNAlater
W just as the whole blood samples “RNAlater”. The RIN values of both
collection methods differ dramatically and represent both the upper and lower limit of the performance of all tested preservation buffers.
Figure 3 Log transformed ratio of hemoglobin transcripts. Log
transformed ratio of hemoglobin transcripts abundant in whole
blood extracts as well as those derived from the LeukoLOCK™ filter
system.
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whole blood sample preparation methods to exclude
hemoglobin transcripts. We extracted the genomic
regions harboring hemoglobin genes from the publicly
available dog genome [33] and mapped all raw reads of
each sample to this hemoglobin reference. Although we
used various methods to deplete globin transcripts from
each sample, sequences mapping to the reference region
could be found in every sample (Table 2). A surprising
24.06% of all reads obtained from sample B1 mapped to
the reference region, followed by 5.46% of the reads in
sample A1 and 1.95% of sample A2. The least number of
reads mapping to the globin reference was found in
sample B2 (0.35%), suggesting that the preparation
method applied to this sample most effectively depleted
globin transcripts.
Lastly, we were interested in the number and identity
of genes that are present in each of the four samples.
The two samples with the largest numbers of contigs,
A2 and A1 also yielded the largest numbers of assigned
genes, 486 and 292 respectively. However, a higher
percentage of assigned contigs were observed in samples
B1 with 57.0% (157 out of 275 contigs) and B2 with
35.0% (109 out of 309 contigs). We extracted the
number of reads per gene in order to evaluate a poten-
tial over-representation of particular genes in the
sample. Additional file 1: Table S2 summarizes the top
10 genes with the largest number of reads per sample
and in concordance with the results described above,
globin genes can be found in three samples, indicating
its omnipresence.
Discussion
Evaluation of RNA preservation buffers and extraction
kits for whole blood
The principle aim of this study was to assess the
performance of commercially available kits and proto-
cols commonly used to preserve and extract RNA from
blood samples. We used total RNA yield, RNA preserva-
tion (RIN) and the degree of DNA contamination as
measures of performance.
DNA contamination is particularly worrisome if ex-
pression profiles are generated with high-throughput
methods because even a single contaminating molecule
can be detected, making sequencing efforts less efficient
and potentially leading to false biological conclusions.
Our DNA contamination tests did reveal a substantial
amount of DNA co-extracted with all RNA extraction
protocols for whole blood. Between 80.0-95.0% of the
whole blood RNA extracts resulted in at least one single
DNA amplicon (Table 1). We observed significant differ-
ences in the extent of contamination depending on the
extraction method used, which might reflect the efficacy
of the different techniques to remove DNA. For
instance, the RiboPure™ protocol is based on a guanidi-
nium thiocyante- phenol- chloroform homogenate that
is extracted under low pH. This procedure is known to
avoid co-extraction of DNA [34] and therefore the
observed 85.0% contaminated extracts were quite
unexpected. Such heavy contamination might be the
result of carryover DNA from the interface during the
phenol-chloroform extraction used in this procedure.
The applied DNase depletion protocols recommended
for each of the tested method should in theory have
removed moderate amounts of DNA (<50 μg DNA/ ml
RNA extract). Surprisingly, irrespective of the extraction
method, an additional DNase treatment was required in
order to ultimately deplete any trace of DNA, which
indicates severely contaminated RNA extracts. This is
somewhat alarming and in agreement with results
reported for other RNA extraction methods [35]. Our
finding implies that great care should be taken in order
to generate endogenous RNA sequence reads on any of
the NGS platforms.
Aside from DNA, other contaminants of RNA extracts
derive from incomplete removal of cellular components
such as proteins, lipids and carbohydrates or traces of
salt and organic solvents stemming from the extraction
procedure itself. With regard to protein depletion in
RNA extracts, determined by the A260/280 ratio, all
methods yielded samples with a ratio averaging above
1.9, which is considered suitable for NGS [36,37]. In
Table 2 Sample preparation procedure and 454 sequencing results
Sample ID Preparation steps # raw reads # reads in contigs # contigs # singletons % globin
reads
A1 ribo-minus>1
st &2
nd strand cDNA
synthesis>NORM>2
nd amp
30,145 9,138 1,066 19,205 5.46
A2 wholeRNA>1
st&2
nd strand cDNA
synthesis>2
nd amp>NORM>3
rd amp
38,601 19,318 2,286 14,079 1.95
B1 globin-minus>ribo-minus>1
st&2
nd
strand cDNA synthesis
21,219 13,075 275 5,987 24.10
B2 globin-minus>ribo-minus>1
st&2
nd
strand cDNAsynthesis>NORM>2
nd amp
17,047 4,391 309 11,168 0.35
# counted.
Abbreviations used for preparation steps are explained in the Supplementary Information Additional files.
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Phenol) and aromatic compounds (i.e. Trizol) that ab-
sorb at 230 nm wavelength, only the RiboPure™ kit
yielded satisfying results with a A260/230 ratio above
1.8, a threshold indicating a low level of contamination.
Although some studies have reported reduced efficiency
of sensitive, downstream applications due to such con-
taminants [36] subsequent sample processing might
eliminate these contaminants and the actual effect could
be negligible when compared to that caused by DNA
contamination.
After depletion of interfering DNA, an accurate
quantification of extracted RNA was possible. Depend-
ing on the extraction kit, the RNA yield for 500 μl blood
is supposed to range between 1.6 μgu pt o5 5μg. While
the yield obtained for PAXgene™ samples is similar to
that suggested by the manufacturers (0.1-10.2 μg/500 μl
blood vs. 1.6- 3.2 μg/500 μl blood as tested by the manu-
facturer), the amount of RNA retrieved using the RNea-
sy
W kit was much lower than stated (0–6.2 μg/500 μl
blood vs. 25–35 μg/ 500 μl blood). Many factors, such as
the individual hydration condition of an animal or blood
density differences in certain parts of the body [34] can
influence the amount of RNA obtained from blood sam-
ples and help to explain the observed variation.
Intriguingly, our study showed that samples extracted
using organic solvents like phenol/chloroform (e.g. Ribo-
Pure™ kit) or TRIzol
W LS reagent resulted in the highest
RNA yields (see also [36,38], Figure 2A). While the com-
bination of phenol/chloroform and RNA bound to glass
fiber columns (as employed by the RiboPure™ kit)
seemed to be very efficient in retrieving RNA [36], the
purely column-based approaches not incorporating
organic solvents (PAXgene™ and RNeasy
W) yielded about
five times lower average RNA quantities.
We observed a significant effect of the collector on the
RNA yield (ANOVA: p=0.02) as well as the preservation
of the RNA (ANOVA: p=0.002). The reasons for this
pattern might include individual differences in sample
handling procedures. However, we need to stress the fact
that the effect of collectors and species could not be dif-
ferentiated since in most cases samples from one species
were collected by a single person under unique condi-
tions (Additional file 1: Table S1). Consequently, our
results imply that either single or correlated effects may
potentially cause differences in RNA yield.
Aside from retrieving sufficient RNA quantities, its in-
tegrity is yet another, perhaps even more important
factor affecting downstream applications [37]. If not
stored properly, low abundance and long transcripts are
rapidly degraded by tissue specific RNases. This process
can affect RNA integrity and result in changes of the
biological expression profile [23-26]. The PAXgene™
(samples stored in PAXgene™ blood buffer) and RNeasy
W
kits (samples stored in RNAprotect
W) both yielded
extracts with the highest RIN values, which makes them
most suitable for sensitive downstream applications.
These two methods also produced the extracts with the
narrowest range of RNA preservation variation and are
among the easiest to use, which highlights the suitability
of these methods whenever samples are collected under
difficult, non-laboratory conditions.
Notably, the two methods resulting in the highest yield
of RNA (TRIzol
W LS, and RiboPure™ with samples
stored in RNAlater
W) produced the extracts with the
lowest and most widely scattered RIN values rendering
its suitability for high-throughput applications question-
able. This was surprising since both storage buffers have
extensively been used to preserve RNA from a broad
range of animal tissues including brain, liver, testis,
tissue culture cells or white blood cells in many different
species (e.g. [9,39-41]). The TRIzol
W LS reagent used
herein is a ready-to-use solution for isolation of total
RNA from liquid samples of different origins (TRIzol
W
LS). One possible explanation for the weak performance
of this method might be the unconventional application
of the storage buffer under field conditions. More
precisely, the solution was aliquoted into RNase free
tubes and provided to collectors. The time elapsed until
actual usage of the buffer for sample collection ranged
from a few weeks to two months and we observed a
decrease in volume in some of these tubes, probably due
to evaporation. Furthermore, it is recommended to keep
the TRIzol
W LS solution away from higher ambient
temperatures and light, factors often unmanageable in
field sites and shown to affect DNA recovery from fecal
samples [42]. In fact, we found a significant difference
between the average RIN values of TRIzol
W LS samples
collected under field conditions (RIN=4.4) and in zoo-
like facilities (RIN=7.9; p=0.005). The inefficiency of
TRIzol
W to serve as preservation agent was previously
also reported by Chiari and Galtier [34]. In summary,
apart from its toxicity, our findings suggest that TRIzol
W
LS would not be the method of choice for blood
collection in the field, especially in warmer climates.
Another commonly used RNA preservation solvent for
whole blood samples is RNAlater
W (e.g. [9]). We found a
surprisingly weak performance of this preservation
method. According to the manufacture’s information
high amount of proteins present in whole blood samples
might lead to insoluble precipitation with RNAlater
W.
One observation supporting this possibility was the high
amount of coagulated blood sampled in RNAlater
W,a
pattern not prevalent in any of the other preservation
buffers storing the same blood volume from the same
animals. Since the preservation process of RNAlater
W
relies upon the permeability of the tissue cells, it is
possible that large blood precipitates hamper the
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interact with the RNA. This is in accordance with other
studies reporting that the size of solid tissue material
stored in RNAlater
W negatively affects the RNA integrity
[36,37]. However, whenever RNAlater
W was used in con-
junction with the filter system it served as the best pre-
servative for RNA as we discuss below.
General performance of a filtering method and its effect
on hemoglobin reduction
We tested the performance of another RNA extraction
method that a priori filters leukocytes from whole blood
and by depleting an excess of hemoglobin mRNA, it ul-
timately reduces the amount of downstream inhibitors
in RNA extracts. However, this filtering procedure
comes with a cost as the average yield of 1.2 μg/ 500 μl
blood in the LeukoLOCK™ filter system was the lowest
in our analysis. Although low in quantity, the RNA itself
was well preserved as indicated by high RIN values
(Table 1, Figure 2B). Only four out of 19 samples
showed a RIN below 7, and we argue that these rare
cases might be due to inappropriate handling of the filter
system by collectors in the field. The handling process
itself is more elaborate and requires a certain degree of
laboratory skill and precautions. It is a multi-step pro-
cedure, which is cumbersome in the field, particularly if
researchers aim to preserve the RNA immediately after
blood collection. In field settings that require animal
handling, researchers are often more focused on the ani-
mal itself and are shorthanded so the immediate proces-
sing of blood through the filter post collection may be
difficult.
An encouraging aspect of this particular system was
the low amount of DNA contamination observed in all
RNA extracts. Only four of 19 samples yielded positive
test PCRs but only two of them amplified in more than
three PCRs. The actual co-extraction of DNA from fil-
tered blood might be lower due to the efficient removal
of the majority of erythrocytes. Whereas, mature mam-
malian erythrocytes contain neither a nucleus nor cell
organelles like mitochondria, immature reticulocytes
released from the bone marrow still harbor a nucleus.
These cells constitute about 1% of the total number of
circulating erythrocytes, which themselves number be-
tween four and six million in a single μl of human blood.
This leaves about 40,000 – 60,000 nuclei exclusively
derived from immature red blood cells and given the
sensitivity of PCRs (i.e. [43]), this number is sufficient to
result in positive test PCRs whenever these cells are not
depleted a priori.
Insufficient elimination of reticulocytes from whole
blood RNA extracts not only affects DNA contamination
but might also change the ratio of highly abundant ver-
sus rare transcripts. Hemoglobin is highly expressed in
blood and warrants special treatment [29,32,44]. A sys-
tem such as LeukoLOCK™ results in the removal of 70%
of hemoglobin transcripts. However, other extraction
methods require additional treatments to deplete these
transcripts which may be necessary to allow the detec-
tion of potential candidates of selection such as low
abundant transcripts of disease related genes [29,45].
Methods for hemoglobin reduction are readily available
but in most cases are designed exclusively for model
organisms.
Efficiency of RNA preparation methods for NGS
Whether finding the causative mutations or simply cata-
loguing the wealth of expressed genes is a priority, nor-
malizing the RNA extract is beneficial [46,47]. In
agreement with previous studies, we found that normal-
ized samples produced the highest number of contigs
but also singleton reads, which are equivalent to rare
transcripts that might harbor valuable information
otherwise not accessible [16,48]. Normalization of RNA
extracts effectively reduces highly abundant transcripts
from the blood but in cases such as the omnipresent
hemoglobin, additional measures need to be considered.
Various methods depleting hemoglobin prior to sequen-
cing exist and can be readily applied at different stages
of sample preparation. We show that the application of
such methods in combination with normalization con-
tributed to a substantial reduction of reads representing
hemoglobin when compared to the 25.0% hemoglobin
reads apparent in the non-normalized sample (B1). This
effect of normalization is only beneficial in qualitative
assessments of an organism’s transcriptome but should
be avoided whenever quantification of gene expression is
desired.
Conclusions
The ultimate decision about which RNA extraction method
to apply may reflect a balance between performance, the
anticipated laboratory effort, the project’s logistics and
finances and the scope of the project. Considering all tests
employed in this study, we conclude that the most
promising RNA storage and extraction method is the
LeukoLOCK™ filter system. Besides its performance, the
method includes practical amenities well suited for field
applications. First, the RNAlater
W soaked membrane of the
filter system allows flexibility in handling time as the RNA
is stable for 24 hours at 37 °C, one week at 25 °C and one
month or more at 4 °C. Second, the LeukoLOCK™ system
works reliably even with small amounts of starting material.
The system was originally designed for 9 ml human blood
but we have demonstrated that much smaller volumes
(1 ml whole blood) are sufficient as well and might
therefore become the method of choice for small species or
individuals that are difficult to handle or suffering from
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processing, which requires a certain familiarity with the
steps in the protocol. However with appropriate practice
and precautions the benefits of this system outweigh the
extra effort, particularly in remote areas with limited access
to electricity and refrigeration.
The second best performing method was the PAXgene™
kit. The preservation buffer is intended for stabilization of
blood for as much as three days at 18- 25 °C or for 5 days
at 2-8 °C. This method has been designed for medical
applications and is therefore more expensive than other
kits. We would like to stress that great care has to be
taken to ensure a sufficient removal of DNA co-extracted
with this RNA extraction kit.
We show that whole blood can be a valuable resource
for transcriptome studies and that the efficiency of NGS
technologies can be maximized by employing appropri-
ate library preparation methods (i.e. normalization).
Consequently, whole blood is a promising and easy
accessible RNA source that has great potential for NGS
studies in ecological and conservation genetics.
Methods
Sample collection for RNA preservation and extraction
evaluation
Whole blood samples were collected from seven carnivore
species, including four Mexican wolves (Canis lupus
baileyi), four grey foxes (Urocyon cinereoargenteus), three
bobcats (Lynx rufus), two coyotes (Canis latrans), four
California sea lions (Zalophus californianus), two harbor
seals (Phoca vitulina) and one California sea otter (Enhydra
lutris) in different facilities/ field settings (Additional file 1:
Table S1). In order to stabilize and preserve the RNA,
we first collected 3 ml whole blood from each individ-
ual into an EDTA coated blood tube. Using a sterile
syringe, approximately 0.5 ml of whole blood was trans-
ferred into each of four tubes containing unique RNA
preservation buffers. These buffers were: RNAlater
W
(Ambion), RNAprotect
W (Qiagen), PAXgene™ blood buffer
(PreAnalytiX, Qiagen) and TRIzol
W LS Reagent (Invitrogen)
(Additional file 1: Figure S1). Whereas RNAlater
W and
RNAprotect
W buffers and tubes were used as provided by
the manufacturer, 1500 μlo fT R I z o l
W LS Reagent was
aliquoted into RNase free 2 ml tubes assuring a blood to
buffer volume ratio of 1:3. A similar volume adjustment
was performed according to Carrol et al. (2007) using the
PAXgene™ blood buffer [49]. The remaining 1 ml whole
blood was processed directly from the EDTA tube through
ap r e - a s s e m b l e dL e u k o L O C K ™ filter system (Ambion). The
filter was flushed with 2 ml PBS (Ambion) and subse-
quently with 2 ml RNAlater
W. Once the filter was saturated
with RNAlater
W, it was sealed until further use. All samples
were shipped to the lab at UCLA immediately after collec-
tion in the field and kept at −20 °C until further processing.
Each individual’s blood was sampled at the same time for
all five approaches simultaneously, except for one coy-
ote where we failed to obtain a LeukoLOCK™ sample
(see Additional file 1: Table S1). The samples were col-
lected according to national guidelines for handling
animals and each institution has acquired the respect-
ive permits required for sampling wild animals. All
procedures were performed by highly qualified
personnel and followed strict ethical guidelines.
Laboratory methods
RNA extraction and quality assessment
The samples were extracted in three batches using com-
mercially available kits by following manufacturer’s pro-
tocols (Table 1). However, some modifications were
incorporated when using the PAXgene™ buffer as sug-
gested for low amounts of starting materials [49]. Spe-
cies and order of samples were randomized between
batches as well as during extractions.
Extracted RNA samples were subjected to kit specific
or recommended DNase treatments. The efficiency of
DNA removal was determined in “no-RT” control PCR
using a regular polymerase. We targeted four loci (see
section below) by using the following conditions. A mas-
termix was prepared with 0.2 U TaqGold (Applied
Biosystems), 1x buffer Gold, 1.5 mM MgCl2, 4% DMSO,
0.2 mM each dNTP, 0.5 μM forward and reverse primer
mix and 1 μl of the non-transcribed RNA. The PCR was
performed on an Eppendorf Mastercycler EP Thermal
cycler (Eppendorf) using the following cycling steps: initial
denaturation at 94 °C for 9 minutes, denaturation at 94 °C
for 20 seconds, annealing temperature 56 °C for 20 sec-
onds, extension at 72 °C for 20 seconds; final extension at
72 °C for 4 minutes; 40 cycles total. PCR amplification
was evaluated on a 2% Agarose gel stained with SYBR Safe
DNA gel stain (Invitrogen) and visualized under UV light.
Samples that successfully amplified in at least two out of
the four PCRs were subjected to an additional DNase
treatment using 4 U of rDNaseI (Ambion) according to
the manufacturer’s recommendation.
In order to evaluate the RNA yield, 10 μl of 1:10 diluted,
DNA-free RNA was used in a Quant-iT™RiboGreen
W
RNA reagent assay (Invitrogen), which uses a dye that
intercalates with nucleic acids and absorbance (260 nm)
could be measured at with a multimode DTX880 plate
reader (Beckman Coulter). RNA integrity was assessed at
the UCLA Sequencing and Genotyping Core using the
RIN values calculated on an Agilent 2100 Bioanalyzer
(Agilent Technologies).
cDNA synthesis and target gene amplification
In order to assess whether prior filtering (LeukoLOCK™
filter system) would efficiently reduce the amount of
hemoglobin transcripts compared to the whole blood
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hemoglobin as well as three housekeeping genes for all
extracted samples. A volume of 4 μl undiluted DNA-free
RNA was reverse transcribed using SuperScript III First-
Strand Synthesis Super Mix (Invitrogen). Since random
hexamers have shown to result in an overestimation of
mRNA copy number by up to 19-fold [50], we used
oligo(dT) primers instead.
Primers were designed based on a multi species
alignment and are available upon request. Previous
findings in humans [51] suggest that three expressed
housekeeping genes are sufficient to normalize qPCR
data from leukocytes. Here we used Ubiquitin C (Ubc),
Phospholipase A2 (YWHAZ) and the human acidic
ribosomal protein (HuPo; [52]).
1
st strand cDNAs were diluted 1:100. Additionally,
samples that were filtered through the LeukoLOCK™ sys-
tem were first diluted 1:2 in order to account for the
1 ml whole blood starting material. 1 μl of each dilution
was used in a 10 μl reaction of LightCycler 480 SYBR
Green I Master mix (Roche). All samples from one indi-
vidual were run at the same time in duplicates and on
the same plate to reduce nuisance parameters such as
technical variations within individuals. We included two
DNA samples as a positive control/ positive calibrator
on each plate. All primers were used in a 0.5 μM end
concentration. The LightCycler protocol included 5 min-
utes activation at 95 °C, 10 seconds denaturing at 95 °C,
primer annealing for 15 seconds at 55 °C, elongation for
30 seconds at 72 °C and a melting curve (95 °C for
5 sec, 65 °C for 2 min and 97 °C). The last step was a
cooling step at 40 °C for 10 sec. The samples were sub-
jected to 50 cycles. In addition to the qPCR set up, we
evaluated the PCR efficiency for each primer pair by
including 12 diluted DNA samples (original concentra-
tion, 1:2, 1:10 and 1:100).
Sample preparation for 454 sequencing
Blood samples from two confined wolves (Mexican and
Arctic wolf) were collected into PAXgene™ blood tubes
and prepared for sequencing utilizing Roches’ 454 GS
FLX Titanium platform following four different proce-
dures. After the extraction of RNA, each extract was
treated differently (Table 2), allowing us to compare the
performance of different methods such as globin reduc-
tion or enzymatic normalization. The actual 454 GS FLX
Titanium library preparation steps included blunt ending
of small DNA fragments, 454 GS FLX Titanium adapter
ligation, various purification steps, emulsion PCR and a
final release of single-stranded DNA fragments. A more
detailed description is provided in the Supplementary
Information. As a proof of concept, we sequenced each
prepared library on a single 1/16 lane of a 454 GS FLX
Titanium run.
Data analyses
DNA contamination, RNA yield and integrity, and
hemoglobin reduction
To first evaluate the extent of DNA contamination of
each RNA extract, we used two different analytical
approaches. Assuming that higher concentration of
DNA in an extract is more likely to yield amplification
success, we first counted the number of positive PCR’s
for each extraction method and performed a Pearson’s
Chi square test. We further calculated the ratio of
positive PCRs for each sample and performed an
ANOVA using the statistical software package R
(http://www.R-project.org).
Total RNA yield was estimated using the Quant-
iT™RiboGreen
W RNA reagent assay comparing the esti-
mates of RNA concentrations against a provided stand-
ard and adjusted for a starting volume of 500 μl whole
blood. To obtain a reliable and comparable measure for
the integrity of all extracted RNA samples, we used the
RNA integrity number (RIN), a measurement that uses
the entire electrophoretic trace of each RNA sample. We
used the Agilent 2100 Bioanalyzer and accompanied
software which calculates the RIN values within a range
of 0 and 10, where 0 represents a totally degraded and
10 a completely preserved RNA sample [53]. An
ANOVA was performed in order to find correlations be-
tween the extraction methods and RNA yield, the stor-
age buffer and RIN factor as well as other variables such
as collection conditions.
To assess the amount of hemoglobin transcripts for
the whole blood and the filtered approach, we processed
the outputs from the LightCycler runs (using LightCycler
480 software) by first undertaking a melting curve analysis
in order to determine that each PCR worked properly and
no unspecific amplification occurred [54]. Samples that
didn’tr e s u l ti nc l e a nm e l t i n gc u r v ep a t t e r n s( i . e .d o u b l e
peaks indicating nonspecific amplification) were
omitted from further analysis and the qPCR was
repeated. In the next step, we estimated the relative
ratios between our target (ß- hemoglobin)a n dt h er e f e r -
ence genes (HuPo, Ubc, YWHAZ) using the relative
quantification software (Efficiency-Method, Applied
Bioscience). This approach compensates for differences
in target and reference gene amplification efficiency
within an experiment and between experiments. The
PCR efficiency for each primer pair was evaluated once
a n du s e da sa ne x t e r n a ls t a n d a r dt h r o u g h o u tt h e
experiment. The target was paired with all three refer-
ence genes and the geometric mean of the resulting
ratios was calculated. By equalizing the average ratios
of the whole blood approaches with 100% of globin
transcripts, we were able to determine the average
reduction of ß- hemoglobin in the filtered samples. To
evaluate the significance of ß- hemoglobin reduction in
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formed both an ANOVA as well as a Students t-test.
Sequence assembly and 454 data analysis
After on-machine filtering of raw reads, all retained
reads of each sample were assembled into contigs using
Roche’s gsAssembler software with minimum overlap of
40 bp and minimum overlap identity of 90%. In order to
evaluate each sample treatment (Table 2) for usefulness
in preparing a transcriptome library from blood samples,
the data was furthermore parsed for total number of
contigs, reads per contig and total number of singletons.
In order to assess the number of reads derived from
hemoglobin transcripts, we extracted the genomic
regions containing hemoglobin genes from the publicly
available dog genome [33] (chr.21:31,293,338-31,325,315
and chrUN:46,802,419-46,803,081) and used this as a
mapping reference for Roche’s gsMapper software apply-
ing the following filters: a minimum overlap of 40 bp
and 95% minimum identity. Lastly, to evaluate the num-
ber of annotated genes sequenced for each of the four
preparation methods, we used the program Blast2GO
[55] to annotate all resulting contigs to known genes.
Additional file
Additional file 1: Supplementary Information. The accompanied
pdf-file provides in depth information regarding the sample preparation
for 454 sequencing, two additional tables and a figure that depicts the
sampling set up [56-58].
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